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Introduction: Compulsive skin picking, being part of the broader category of impulse control disorders, is
considered a residual diagnosis in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text
Revision. It is characterized by excessive scratching or picking of normal skin, or skin with minor surface
irregularities, and occurs in 2% of patients attending dermatology clinics. Despite the clinical relevance of this
disorder, no clear guidelines are available yet; clinical management is, therefore, compromised and the day-to-day
clinical practice is burdened by difficulties. Studies on selective serotonin reuptake inhibitors and anti-epileptic
drugs have provided limited results. The association between anti-depressants and anti-epileptics has been found
to be beneficial in some impulse control disorders, but in skin picking no previous studies have been conducted on
this pharmacological approach. There are very few reports on the efficacy of anti-psychotics in skin picking.
Case presentation: The therapeutic path described in this case report produced good results for a 59-year-old
Caucasian woman. The first therapeutic approach, with fluvoxamine and oxcarbazepine was partially effective; then, the
suspension of oxcarbazepine and haloperidol augmentation of fluvoxamine were adopted. After 10 weeks, a significant
improvement of the disease was observed: the clinical picture and the associated symptoms were nearly solved.
Conclusions: To the best of our knowledge, this is the first article reporting the association of fluvoxamine and
haloperidol in skin picking disorder. It might be useful to perform further research regarding the treatment of skin
picking disorder: in clinical practice, several variables might limit the choice of certain drugs. Therefore, it would be
useful for the clinician to be aware of other therapeutic options.
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Compulsive skin picking (also known as neurotic excori-
ation) is characterized by excessive scratching or picking
of normal skin or skin with minor surface irregularities,
and it predominantly affects women in their teens to late
30s [1]; although skin picking should deserve more atten-
tion, being part of the broader category of impulse control
disorders (ICDs), it is considered a residual diagnosis in
the Diagnostic and Statistical Manual of Mental Disor-
ders, Fourth Edition, Text Revision (DSM-IV-TR) [2]. Re-
gardless, skin picking behaviors are quite frequent in the
general population, as demonstrated in a study conducted
in the USA which took into consideration conditions* Correspondence: c.calandra@unict.it
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reproduction in any medium, provided the orranging from mild to clinically significant ones [3]. In
addition, skin picking occurs in 2% of patients attending
dermatology clinics and it is associated with medical com-
plications (for example, infection), significant distress and
functional impairment [1].
Despite the significant clinical impact of skin picking
disorder, no clear therapeutic guidelines are available to
date. Different selective serotonin reuptake inhibitors
(SSRIs) have been found to be effective in pathologic
skin picking, with a significant improvement in picking
behavior and a resultant reduction of the lesions [4,5].
However, some reports on SSRIs have provided conflict-
ing results [6].
Further studies have demonstrated the efficacy of anti-
epileptic drugs in skin picking disorder [7]. Previous
reports suggest that the association between anti-
depressants and anti-epileptic drugs might be beneficial in
some ICDs [8], but no previous studies seem to have beend. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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proach in skin picking.
Only a few reports point out the beneficial role of low
doses of neuroleptic drugs for the treatment of skin pick-
ing [9,10].
This limited data highlights the need for further re-
search on the therapeutic options to be adopted for this
complex disorder. Here, we describe the association of
fluvoxamine and haloperidol as a possible therapeutic
approach to skin picking disorder. The potential useful-
ness of this treatment is illustrated in our patient’s case,
as described below.Case presentation
A 59-year-old Caucasian woman with a three-year his-
tory of several dermatological consultations and investi-
gations (results all negative) presented to our Psychiatry
Unit for consultation on the advice of her general practi-
tioner and her dermatologist. She had been treated,
without success, with various oral and topic antibiotics,
even in association with corticosteroids.
The anamnestic data collection revealed that our pa-
tient was born with congenital cataracts in both eyes
that made her severely sight impaired. Notwithstanding,
she is a very active and relatively independent person.
In addition, she experienced traumas in her early life:
her three-year-old brother died prematurely, and her 10-
year-old sister was burnt to death, in her presence, in a
tragic domestic accident.
She began to pick at her skin three years ago, causing
herself lesions around the margin of the lips, on her
cheeks, chin and nose. Her skin picking was frequent
and lasted for hours; it was associated with emotional
stress followed by a feeling of relief after picking.
In that period, she was forced to change the arrangement
of the furniture and objects in the house due to urgent re-
furbishment. Being visually impaired, these problems
caused her further distress. She reported that her picking
behavior was due to different stimuli, such as itching, pain,
and burning sensations. She was aware that these feelings,
which resulted in compulsive skin picking, were irrational;
she did not feel she had any face defects or deformity, but
she could not stop picking.
Our patient reported a strong ‘urge’ to pick her skin: a
sensation which occurred many times during the day fol-
lowed by a feeling of relief the moment she picked her
skin; all her attempts to resist such an urge required a
huge effort and caused serious distress.
This woman has experienced early trauma, stressful
events, solitude (being single and living alone), a severe
handicap, and she has to take care of herself. She mani-
fested her distress, together with anger and frustration,
through her body in a self-destructive way. She picked ather skin causing herself severe lesions; her picking be-
havior was frequent and sometimes lasted hours.
At her first visit, the general physical examination was
within normal limits, apart from the visual impairment
and the skin lesions. A dermatological examination
revealed the presence of multiple symmetrical facial
ulcers and hyper-pigmented areas on normal skin or on
pimples, particularly in the area of her cheeks, chin, nose
and around her lips. The lesions ranged from a size of
around 1cm to 3cm, and appeared in different develop-
mental stages, ranging from ulcers to bruises, scabs, and
scar areas, some of which were infected. Our patient,
owing to her visual impairment, could not clearly see
the injuries that she caused herself. Hence, when shown
her magnified photographs, she was shocked by the ex-
tent of her facial lesions, which made her wonder what
reactions her aesthetic condition would provoke in the
people she met.
The results of a mental status examination did not re-
veal any mood or psychotic disorders, or other Axis I
disorders.
The Structured Clinical Interview for DSM-IV Axis II
Personality Disorders (SCID-II) [11] revealed traits of
obsessive-compulsive personality disorder, as is often
observed in skin pickers [12].
Our patient was treated with fluvoxamine 300mg/day
and oxcarbazepine 600mg/day, with a reduction of urges
to pick her skin and a certain improvement in the extent
of the lesions, but she was never completely free from the
picking behavior; in addition, she noted considerable
drowsiness.
Therefore, we changed the therapeutic program: we
suspended oxcarbazepine and we added haloperidol
2mg/ml, seven drops per day (0.7mg/day), to the main-
tenance therapy of fluvoxamine. After 10 weeks, she
came for follow-up, very grateful of what she defined as
a ‘full recovery’, having never felt, until now, such a relief
from her symptoms. With the new therapy, unlike the
previous one, she was able to completely master her ten-
dency to pick her skin, with the subsequent significant
improvement of her clinical conditions.
Discussion
‘Nervous habits’ such as nail biting, hair pulling and skin
picking are often seen by general practitioners as com-
mon and benign, despite the disfiguring effects and the
distress related to these disorders [3]. Pickers, in particu-
lar, experience a variety of psychosocial difficulties, in-
cluding social embarrassment and avoidance, loss of
productivity at work, anxiety, depression and suicidal
ideation [13]. Even if pathological skin picking is quite a
frequent and disabling disorder, it is not classified as a
separate disorder in the DSM-IV-TR. Some authors have
suggested skin picking to be a part of the obsessive-
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will probably include it in this diagnostic group as a
better-defined diagnostic label (http://www.dsm5.org).
Skin picking is thus achieving a certain level of attention;
however, at present research for the treatment of this
disorder is sparse and no clear guidelines are available.
Consequently, the choice of the therapy is almost com-
pletely left in the hands of the clinicians.
In our patient’s case, our therapeutic choice initially con-
sisted of oxcarbazepine and fluvoxamine; following a par-
tial success, our patient presented an almost complete
recovery after we suspended oxcarbazepine and added
haloperidol. In the literature, a limited number of con-
trolled trials have suggested the efficacy and tolerability of
SSRIs in the treatment of skin picking; this is one of the
reasons this disorder has been related with obsessive-
compulsive disorder. In fact, these anti-depressants have
been extensively and successfully tested in obsessive-
compulsive disorder and, moreover, skin picking is fre-
quently associated with depression [4,5]. However, there
are some reports that these drugs could even trigger a skin
picking behavior [6]. The association between anti-
depressant and anti-epileptic drugs has been found to be
beneficial in some ICDs [8], but to date no data about this
pharmacological approach in skin picking are available.
With regard to anti-psychotics, olanzapine and paliperi-
done have been considered efficacious in only a few cases
of skin picking [9,10]. In our patient’s case we preferred to
use haloperidol in place of olanzapine because of the risk of
metabolic side effects, especially, in overweight individuals,
as was the situation with our patient. Paliperidone was not
used because drug-induced obsessive symptoms have been
reported with this substance [14] and this effect might
make its use risky in a disease such as skin picking. The
efficacy of haloperidol was probably due to its anti-
dopaminergic function. Some authors believe self-injurious
behaviors may be the result of an excessive stimulation of
dopamine receptors in mesolimbic structures [15].
In this context of growing knowledge, the ‘future’ of
skin picking, a very complex but fascinating disorder,
has yet to be written; further research on the potential
usefulness of other drugs is needed, also taking into ac-
count new findings in the neurobiological field.
Conclusions
The clinical impact of skin picking disorder should not
be underestimated, for the distress that characterizes it
and for its disfiguring effects, often on exposed parts of
the body. The choice of the right therapy is a challenge
in clinical practice, since several variables might limit
the use of certain drugs. To the best of our knowledge,
this is the first case reporting the efficacy of the associ-
ation of haloperidol and fluvoxamine in this disorder. It
would be useful to improve research about skin pickingand its treatment, to provide clinicians a certain, widely
recognized, range of therapeutic options.
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